But, again, the figures are not completely representative. The numbers have been heavily influenced by the inclusion of a few very big deals, including the tie-up between drugs giant Sanofi-Synthelabo and Aventis for US$74bn, the JP Morgan Chase and Bank One deal, worth $58bn, and the Cingular and AT&T get-together, which is valued at $41bn.